Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8(+) T cells

Human Cytomegalovirus (CMV) reactivation remains a major source of morbidity in patients after solid organ and hematopoietic stem cell transplantation (HSCT). Adoptive T cell therapy (ACT) with CMV-specific T cells is a promising therapeutic approach for HSCT recipients, but might be counteracted by...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Schlott, Fabian, Steubl, Dominik, Ameres, Stefanie, Moosmann, Andreas, Dreher, Stefan, Heemann, Uwe, Hösel, Volker, Busch, Dirk H., Neuenhahn, Michael
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5831000/
https://ncbi.nlm.nih.gov/pubmed/29489900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193554
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares